Reversal of sedation does not mean the underlying critical illness has resolved.
A ninety-three-year-old with renal disease and aspiration pneumonia developed persistent impaired consciousness. After a response to a flumazenil test, continuous infusion was followed by neurological recovery and was tapered over seventy-two hours. The patient later died from sepsis.
The case provides no controlled estimate of infusion benefit or adverse-event frequency. A favorable antagonist response does not independently establish the exact drug, concentration or sole cause of altered consciousness.
Keep neurological and overall outcomes separate. An account stating successful treatment without the later course would be incomplete. For causation review, examine infection, organ dysfunction, actual sedative exposure and respiratory observations alongside the antagonist response; this case cannot establish a broadly safe infusion strategy for other patients.
Source: PMC12368922, supplied full-text paper. Findings are paraphrased; forensic implications are an interpretation.
Related: Lithium Toxicity, Lorazepam and Recovery: Two Treatment Processes Overlapped.